GetChain News
中简 中繁 EN
GetChain News
Toggle sidebar

Online/Update

News linked to both this project and an event.

Galaxy’s Annual Report Released: Core Business Profitable, Stock Price Surges Over 11% in a Single Day

According to The Block, Galaxy Digital released its full-year 2025 financial results. Although the company reported a net loss of $241 million for the year, its core business achieved profitability on a non-GAAP basis. Specifically, its digital asset business segment—which includes trading, lending, asset management, and staking services—generated adjusted gross profit of $505 million. Boosted by this performance, GLXY’s stock closed up 11.3% that day at $21.15. CEO Mike Novogratz stated that the company’s Helios data center has received ERCOT approval to expand capacity to 1.6 gigawatts, and CoreWeave has signed a long-term lease for 800 megawatts of that capacity, securing a stable, long-term revenue stream. He emphasized that the industry is shifting from “narrative-driven” to “infrastructure-driven,” and Galaxy will continue to focus on core areas including the institutional market, asset management, onchain infrastructure, and AI data centers.

AlphaTON Capital Plans to Raise $43 Million to Expand AI Computing Infrastructure

According to The Block, AlphaTON Capital has announced plans to raise $43 million through a strategic partnership with Vertical Data Inc. to expand its AI compute infrastructure; the transaction is expected to close in Q2 2026. AlphaTON CEO Brittany Kaiser stated that the funding will be used to deploy additional NVIDIA B300 GPUs, with the core objective of advancing the convergence of AI, digital assets, and confidential computing—and scaling up the platform’s overall compute capacity. On the business front, AlphaTON not only holds a substantial amount of TON tokens as corporate treasury assets but also actively participates in building infrastructure for the Telegram and TON ecosystems, with key investment focus areas including Cocoon, Telegram’s decentralized AI platform. Background-wise, AlphaTON was formed through the restructuring and transformation of former biotech public company Portage Biotech Inc., which had previously focused on cancer therapy research; the company completed the spin-off of its cancer therapy subsidiary in February this year.